ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

VTRS Viatris Inc

10.05
-0.06 (-0.59%)
Jun 18 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Viatris Inc VTRS NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
-0.06 -0.59% 10.05 19:00:00
Open Price Low Price High Price Close Price Previous Close
10.10 9.925 10.25 10.05 10.11
more quote information »

Recent News

Date Time Source Heading
6/07/202405:59PRNUSViatris to Report Second Quarter 2024 Financial Results on..
6/04/202405:59PRNUSViatris to Participate in the Goldman Sachs 45th Annual..
6/03/202406:16EDGAR2Form 8-K - Current report
6/03/202405:59PRNUSViatris Appoints Rogerio Vivaldi Coelho, M.D., to Board of..
5/31/202405:59PRNUSViatris to Participate in the Jeffries Global Healthcare..
5/28/202417:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
5/28/202415:04EDGAR2Form 144 - Report of proposed sale of securities
5/21/202405:59PRNUSViatris Publishes 2023 Sustainability Report: Building..
5/09/202406:47IHMARKETNEWSU.S. Index Futures Dip, Bank of England Holds Interest Rates..
5/09/202406:44EDGAR2Form 8-K - Current report
5/09/202405:59PRNUSViatris Reports Strong First Quarter 2024 Financial Results..
5/02/202416:00PRNUSViatris to Participate in the BofA Securities 2024 Health..
5/01/202405:59PRNUSViatris Expands its Wellbeing Program with the Launch of..
4/16/202415:30PRNUSViatris to Report First Quarter 2024 Financial Results on..
4/15/202407:00PRNUSViatris Appoints Corinne Le Goff as Chief Commercial Officer
4/15/202405:59PRNCAViatris annonce le lancement de la première version..
4/01/202405:59PRNUSViatris Announces the Launch of RYZUMVl™ (Phentolamine..
3/27/202405:59PRNUSViatris Hosts R&D Event Focusing on its Collaboration with..
3/05/202419:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
3/05/202419:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
3/05/202419:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
3/05/202418:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
3/05/202418:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
3/05/202418:26EDGAR2Form 3 - Initial statement of beneficial ownership of..
3/04/202417:11EDGAR2Form 144 - Report of proposed sale of securities
2/28/202406:39EDGAR2Form 8-K - Current report
2/28/202405:30PRNUSViatris Reports Fourth-Quarter and Full-Year 2023 Financial..
2/28/202400:00PRNUSViatris and Idorsia Enter Into Significant Global Research..
2/23/202417:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/16/202417:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/15/202416:18EDGAR2Form 144 - Report of proposed sale of securities
2/05/202405:59PRNUSViatris to Announce Fourth Quarter and Full-Year 2023..
1/30/202415:40EDGAR2Form 8-K/A - Current report: [Amend]
1/19/202405:56PRNUSViatris recognised as a Top Employer 2024 in the UK for the..
1/05/202417:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/04/202419:28EDGAR2Form 144 - Report of proposed sale of securities
12/21/202315:05PRNUSViatris to Participate in 42nd Annual J.P. Morgan Healthcare..
12/15/202317:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/15/202316:04EDGAR2Form 8-K/A - Current report: [Amend]
12/15/202316:00EDGAR2Form 8-K - Current report
12/15/202315:45PRNUSViatris Continues its Preparations for Phase 2 of its..
12/15/202315:14EDGAR2Form 8-K - Current report
12/15/202315:12EDGAR2Form 8-K - Current report
12/15/202315:05PRNUSViatris Shareholders Re-elect All Nominated Directors and..
12/14/202316:31EDGAR2Form 144 - Report of proposed sale of securities
11/24/202317:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/24/202315:30EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
11/24/202312:02EDGAR2Form 144 - Report of proposed sale of securities
11/14/202307:00PRNUSViatris to Participate in the Jefferies London Healthcare..
11/13/202307:00PRNUSViatris and Theravance Biopharma Announce Positive Top-Line..

Your Recent History

Delayed Upgrade Clock